DNLI vs GPN · rev $3.6M vs P/E 24, rev $6.29B
Denali Therapeutics Inc (DNLI) versus Global Payments Inc (GPN) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
DNLI currently screens at market cap $2.11B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Not investment advice. Open the DNLI and GPN stock pages for the full models.
Not investment advice.